For this report card, LC has focused on five subtypes in 12 member countries. These five subtypes were chosen because they had the highest number of respondents in the 2016 LC GPS (10% or higher) and, thus, ensured statistical significance.

The five subtypes are: 

  • CLL 
  • FL
  • HL
  • WM

Unfortunately, the barriers to receiving appropriate and timely care have not gone away, as will be demonstrated in the 2016 LeIP Report Card. Building on the findings from the 2016 Lymphoma GPS, LC undertook to investigate whether barriers to receiving treatment were more pronounced in some lymphoma subtypes compared with others based on the respondents’ country of residence.

As well, LC examined the psychosocial barriers, physical and medical issues, the level of understanding of the different subtypes among respondents and the level of support provided by physicians.

The 12 member countries were chosen rather than all member countries to allow for the inclusion of information from the GPS to create a full situation analysis.

For the other 32 member countries,there were insufficient data from the GPS to provide a situation analysis. Owing to insufficient responses, no findings on issues in Africa or the Middle East are included in this report.


Download the 2016 LeIP Report Card on Lymphomas here.





Global Database

Information by country, region and/or subtype on treatments, clinical trials and incidence/mortality rates.

Resource Library

Over 2,000 pieces of information on lymphoma diagnosis, treatment, research, support and lifestyle.

logo europe




The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or
require more detailed information on the best course of treatment for you.

Our website does not host any form of advertisement. Last updated: 02/19/19. Copyright © 2018 Lymphoma Coalition. All rights reserved.